ArticleFrontiers in epidemiology2026
Understanding the problem of chronic kidney disease in the Republic of Kazakhstan: the study on prevalence and patients' health behaviors.
Article in Frontiers in epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is a lack of epidemiological data on the prevalence of chronic kidney disease (CKD) and hemodialysis, as well as associated health behaviors in Central Asia, although this information is needed for the management of healthcare services. Therefore, this study was undertaken to analyze the prevalence of CKD and hemodialysis in the population of selected provinces of Kazakhstan over the period from 2017 to 2019. In addition, we investigated health literacy and self-management of patients with CKD. Methods: This study had a two-stage design. The first stage was a retrospective cross-sectional study, which relied on the data obtained from the electronic database maintained by the Republican Center for Health Development. Point and period prevalence of CKD and hemodialysis were calculated per million population (PMP). The second stage had a prospective cross-sectional design and involved 79 CKD patients presenting at a single nephrology center. Results: The point prevalence of CKD was the highest in 2017 ranging from 137.0 PMP in North Kazakhstan province to 388.8 PMP in Turkestan province. The point prevalence of hemodialysis was higher than that of CKD and ranged from 359.3 PMP (East Kazakhstan province, 2017) to 629.3 PMP (Kostanay province, 2018). There was a growth in the point prevalence of hemodialysis over the period of 3 years in all provinces, apart from Kostanay. CKD patients had suboptimal knowledge of their disease and less than adequate self-management skills with certain gender-specific differences. Conclusion: Additional studies are required to address the knowledge gap concerning determinants of CKD in the population of Kazakhstan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.